Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Optomed

2.41 EUR

+1.05 %

5,654 following
Corporate customer

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

+1.05 %
-9.91 %
-36.07 %
-36.07 %
-34.78 %
-37.65 %
-38.68 %
-60.36 %
-47.38 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
51.7M EUR
Turnover
96.2K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Buy
Target price
Updated
11.02.2026
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
6.5.
2026

Interim report Q1'26

8.5.
2026

General meeting '26

14.8.
2026

Interim report Q2'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Kyllähän tämä ihan hyvältä kuulostaa: The Bottom Line When asked to describe the value of the Aurora AEYE to their organization and patients, the answer was simple: “Essential. We’ve become dependent on it.” Aurora AEYE is FDA cleared, reimbursable with CPT code 92229, as well as...
2 hours ago
29
Optomed US came out of the closet with this: LinkedIn How One Primary Care Network Transformed Diabetic Eye Care with AI-Powered... The Aurora AEYE DR screening system is proven in real world applications. Still the only FDA-cleared handheld non-mydriatic fundus camera with integrated...
2 hours ago
by Mr. Stock
20
Black Enterprise – 2 Apr 26 New AI-Powered Camera Makes Diabetes Detection More Accessible Diabetic screening capabilities are advancing as artificial intelligence cameras that detect diabetes are rolling out to primary care clinics. Est. reading time: 2 minutes This is almost certainly...
4 hours ago
by Artoh1
13
Below is the growth by revenue recognition period from 2024 to 2025. Q1 Q2 Q3 Q4 Total €287,000 €366,000 €257,000 €132,000 €1,042,000 Growth should accelerate. Epic and ISO27001, in particular, are driving or at least should be driving a stronger scale for larger operators. I wouldn...
6 hours ago
by Due Diligence
9
It does look like the images show a Chinese CFC-X camera. Optomed is tagged, of course, but it raises doubts about Optomed’s involvement in this project.
16 hours ago
8
I wonder how many such cases are currently brewing under the surface… these seem to progress under the radar
52 minutes ago
by Mr. Stock
6
Exactly, and it’s a third of the price of Aurora. They probably won’t get a big slice from those developing markets, and even less certified versions might be good enough for AI, as they work quite well on average, even if they don’t produce the sharpest ROI curve. redsunoptical....
15 hours ago
by Puutaheinää
5
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.